Trademark: 79331944
Word
GYROSCOPE
Status
Registered
Status Code
700
Status Date
Tuesday, January 24, 2023
Serial Number
79331944
Registration Number
6959540
Registration Date
Tuesday, January 24, 2023
Mark Type
3000
Filing Date
Friday, August 6, 2021
Published for Opposition
Tuesday, November 8, 2022

Trademark Owner History
Gyroscope Therapeutics Limited - Original Registrant

Classifications
41 Education and training services in the nature of online instruction, didactic courses and workshops, hands-on workshops in the field of medical and surgical procedures and in the field of the operation and use of medical and surgical equipment; training services in the field of ophthalmic surgical procedures; training services in the field of ophthalmic surgical equipment and the use and operation thereof; educational services, namely, conducting in-person classes, seminars, conferences, exhibits, and workshops in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; educational services, namely, conducting online classes, seminars, conferences, exhibits, and workshops in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; educational services, namely, providing in-person instruction in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; educational services, namely, providing online instruction in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; interactive in-person training services in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; interactive online training services in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment
5 Medical and veterinary preparations for therapeutic purposes, namely, for the prevention and treatment of age-related macular degeneration; preparations for cell therapy, namely stem cells for medical purposes; pharmaceutical preparations for gene therapy; biologic preparations for medical purposes, namely, viral vectors for the delivery of gene therapy; biologic preparations for use in the treatment of diseases and disorders that cause blindness; gene therapy medical preparations for use in treatment of genetically based diseases and disorders; gene therapy preparations for medical purposes, namely, preparations for treating gene-linked diseases and disorders; gene therapy medical preparations for use in the treatment of ophthalmological diseases and disorders; gene therapy medical preparations for use in the treatment of diseases and disorders that cause blindness; gene therapy medical preparations for use in the treatment of complement pathway-related or complement pathway-mediated diseases or disorders
10 Medical and surgical apparatus and instruments for medical and veterinary use; medical devices, namely, devices for administering ophthalmic injections and for facilitating the administration of ophthalmic injections; ophthalmic surgery medical devices and surgical instruments; adhesive pads for medical and surgical use, namely, pads to provide stabilization of instruments for sub-retinal delivery of pharmaceutical, biologic, cell therapy, and gene therapy products via the suprachoroidal space; ophthalmic apparatus and instruments, namely, surgical instruments for use in the delivery and administration of fluids, biologics and pharmaceuticals during ophthalmic procedures and surgery; apparatus and instruments for dispensing or delivering preparations into the eye or structures thereof, namely, medical devices for sub-retinal delivery via suprachoroidal space of pharmaceutical and biologic, cell therapy and gene therapy products; adhesive pads for medical use, namely, to provide stabilization of instruments for sub-retinal delivery of pharmaceutical, biologic, cell therapy, and gene therapy products via the suprachoroidal space; magnetic pads for medical use, namely, to provide stabilization of instruments for sub-retinal delivery of pharmaceutical, biologic, cell therapy, and gene therapy products via the suprachoroidal space
The mark consists of the word "GYROSCOPE" in black with the "O" in "GYRO" formed by a stylized depiction of an eye formed by two curved lines, one on the left in green and one on the right in orange that surround a teal circle in the middle; the color white represents background and/or transparent area and is not claimed as a feature of the mark.
The colors black, green, orange and teal are claimed as a feature of the mark.

Trademark Events
Jul 19, 2023
New Representative At Ib Received
May 23, 2023
Final Decision Transaction Processed By Ib
May 3, 2023
Final Disposition Notice Sent To Ib
May 3, 2023
Final Disposition Processed
Apr 24, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jan 24, 2023
Notice Of Registration Confirmation Emailed
Jan 24, 2023
Registered-Principal Register
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 3, 2022
Approved For Pub - Principal Register
Oct 3, 2022
Examiner's Amendment Entered
Oct 3, 2022
Notification Of Examiners Amendment E-Mailed
Oct 3, 2022
Examiners Amendment E-Mailed
Oct 3, 2022
Examiners Amendment -Written
Oct 1, 2022
Teas/Email Correspondence Entered
Sep 30, 2022
Correspondence Received In Law Office
Sep 30, 2022
Teas Response To Office Action Received
Sep 1, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 1, 2022
Teas Change Of Correspondence Received
Sep 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 1, 2022
Teas Change Of Owner Address Received
Jun 22, 2022
Refusal Processed By Ib
May 27, 2022
Non-Final Action Mailed - Refusal Sent To Ib
May 26, 2022
Refusal Processed By Mpu
May 13, 2022
Non-Final Action (Ib Refusal) Prepared For Review
May 12, 2022
Non-Final Action Written
May 6, 2022
Assigned To Examiner
Apr 2, 2022
New Representative At Ib Received
Feb 2, 2022
Application Filing Receipt Mailed
Jan 29, 2022
New Application Office Supplied Data Entered
Jan 27, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24